Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity

Food and Chemical Toxicology

Volumn 110, Issue , 2017, Pages 316-324

  Morovic, Wesley ^a   Roper, Jason M ^a   Smith, Amy B ^a   Mukerji, Pushkor ^a   Stahl, Buffy ^a   Rae, Jessica Caverly ^a   Ouwehand, Arthur C ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Acute toxicity; Bifidobacterium; Genomics; Lactobacillus; Probiotics; Rats

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL TOXIN; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; PROBIOTIC AGENT; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN; VIRGINIAMYCIN; ANTIINFECTIVE AGENT;

ACUTE TOXICITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; FEMALE; GENETIC RISK; IN VITRO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; NONHUMAN; RAT; TETW GENE; TOXICITY TESTING; ANIMAL; BACTERIAL GENOME; DRUG EFFECTS; GENETICS; GENOMICS; PHYSIOLOGY; PRECLINICAL STUDY; RISK FACTOR; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM ANIMALIS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOME, BACTERIAL; GENOMICS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS;

EID: 85032658081     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.10.037     Document Type: Article

References (98)

1. Abe, F., Yaeshima, T., Iwatsuki, K., Safety evaluation of two probiotic bifidobacterial strains, Bifidobacterium breve M-16V and Bifidobacterium infantis M-63, by oral toxicity tests using rats. Biosci. Microflora 28:1 (2009), 7–15.
2. Agu, C.A., Klein, R., Schwab, S., König-Schuster, M., Kodajova, P., Ausserlechner, M., et al. The cytotoxic activity of the bacteriophage λ-holin protein reduces tumour growth rates in mammary cancer cell xenograft models. J. Gene Med. 8:2 (2006), 229–241.
3. Altermann, E., Russell, W.M., Azcarate-Peril, M.A., Barrangou, R., Buck, B.L., McAuliffe, O., et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc. Natl. Acad. Sci. U.S.A. 102:11 (2005), 3906–3912.
4. Aziz, R.K., Bartels, D., Best, A.A., DeJongh, M., Disz, T., Edwards, R.A., et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics, 9(1), 2008, 75.
5. Barefoot, S.F., Klaenhammer, T.R., Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ. Microbiol. 45:6 (1983), 1808–1815.
6. Barnard, J.P., Stinson, M.W., The alpha-hemolysin of Streptococcus gordonii is hydrogen peroxide. Infect. Immun. 64:9 (1996), 3853–3857.
7. Bernardeau, M., Vernoux, J.P., Henri-Dubernet, S., Gueguen, M., Safety assessment of dairy microorganisms: the Lactobacillus genus. Int. J. Food Microbiol. 126:3 (2008), 278–285.
8. Bourdichon, F., Casaregola, S., Farrokh, C., Frisvad, J.C., Gerds, M.L., Hammes, W.P., et al. Food fermentations: microorganisms with technological beneficial use. Int. J. Food Microbiol. 154:3 (2012), 87–97.
9. Briczinski, E.P., Loquasto, J.R., Barrangou, R., Dudley, E.G., Roberts, A.M., Roberts, R.F., Strain-specific genotyping of Bifidobacterium animalis subsp. lactis by using single-nucleotide polymorphisms, insertions, and deletions. Appl. Environ. Microbiol. 75:23 (2009), 7501–7508.
10. Broadbent, J.R., Neeno-Eckwall, E.C., Stahl, B., Tandee, K., Cai, H., Morovic, W., et al. Analysis of the Lactobacillus casei supragenome and its influence in species evolution and lifestyle adaptation. BMC Genomics, 13, 2012, 533.
11. Chakraborty, A., Gosh, S., Chowdhary, G., Maulik, U., Chakrabarti, S., DBETH: a database of bacterial exotoxins for human. Nucleic Acids Res. 40:D1 (2012), D158–D169.
12. Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L., Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71:1 (2001), 1–20.
13. Collins, E.B., Aramaki, K., Production of hydrogen peroxide by Lactobacillus acidophilus. J. Dairy Sci. 63:3 (1980), 353–357.
14. Collins, J.D., Noerrung, B., Budka, H., Andreoletti, O., Buncic, S., Griffin, J., et al. Scientific opinion on risk based control of biogenic amine formation in fermented foods. EFSA J., 9, 2011, 2393.
15. Coton, E., Coton, M., Multiplex PCR for colony direct detection of Gram-positive histamine- and tyramine-producing bacteria. J. Microbiol. Methods 63:3 (2005), 296–304.
16. Darling, A.E., Mau, B., Perna, N.T., Progressivemauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One, 5(6), 2010, e11147.
17. de Las Rivas, B., Marcobal, A., Munoz, R., Improved multiplex-PCR method for the simultaneous detection of food bacteria producing biogenic amines. FEMS Microbiol. Lett. 244:2 (2005), 367–372.
18. de las Rivas, B., Marcobal, A., Carrascosa, A.V., Munoz, R., PCR detection of foodborne bacteria producing the biogenic amines histamine, tyramine, putrescine, and cadaverine. J. Food Prot. 69:10 (2006), 2509–2514.
19. Dobson, A., Cotter, P.D., Ross, R.P., Hill, C., Bacteriocin production: a probiotic trait?. Appl. Environ. Microbiol. 78:1 (2012), 1–6.
20. EFSA, Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J., 10(6), 2012, 2740.
21. Endres, J.R., Clewell, A., Jade, K.A., Farber, T., Hauswirth, J., Schauss, A.G., Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food Chem. Toxicol. 47:6 (2009), 1231–1238.
22. Forssten, S.D., Röytiö, H., Hibberd, A.A., Ouwehand, A.C., The effect of polydextrose and probiotic lactobacilli in a Clostridium difficile-infected human colonic model. Microb. Ecol. Health Dis., 26, 2015.
23. Gillor, O., Etzion, A., Riley, M.A., The dual role of bacteriocins as anti-and probiotics. Appl. Microbiol. Biotechnol. 81:4 (2008), 591–606.
24. Grzeskowiak, L., Sales Teixeira, T.F., Bigonha, S.M., Lobo, G., Salminen, S., Ferreira, C.L., Gut Bifidobacterium microbiota in one-month-old Brazilian newborns. Anaerobe 35:Pt B (2015), 54–58.
25. Gueimonde, M., Florez, A.B., van Hoek, A.H., Stuer-Lauridsen, B., Stroman, P., de los Reyes-Gavilan, C.G., et al. Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis. Appl. Environ. Microbiol. 76:10 (2010), 3364–3369.
26. Härtlein, M., Schießl, S., Wagner, W., Rdest, U., Kreft, J., Goebel, W., Transport of hemolysin by Escherichia coli. J. Cell. Biochem. 22:2 (1983), 87–97.
27. Hill, C., Virulence or niche factors: what's in a name?. J. Bacteriol. 194:21 (2012), 5725–5727.
28. Hoover, D.G., Steenson, L.R., Bacteriocins of Lactic Acid Bacteria. 2014, Academic Press.
29. Hung, L.W., Wang, I.X., Nikaido, K., Liu, P.Q., Ames, G.F., Kim, S.H., Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 396:6712 (1998), 703–707.
30. ISO, 10932:2010 (IDF 223:2010) Milk and milk products – determination of the minimal inhibitory concentration (MIC) of antibiotics applicable to bifidobacteria and non-enterococcal lactic acid bacteria (LAB). Int. Organ. Stand, 2010, 1–31 ICS: 67.100.01.
31. Jia, X., Wang, W., Song, Y., Li, N., A 90-day oral toxicity study on a new strain of Lactobacillus paracasei in rats. Food. Chem. Toxicol. 49:5 (2011), 1148–1151.
32. Kaiserlian, D., Lalles, J.P., Peltre, G., Penninks, A., Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed. EFSA J., 8(7), 2010, 1700.
33. Karpichev, I.V., Cornivelli, L., Small, G.M., Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism. J. Biol. Chem. 277:22 (2002), 19609–19617.
34. Kazimierczak, K.A., Flint, H.J., Scott, K.P., Comparative analysis of sequences flanking tet (W) resistance genes in multiple species of gut bacteria. Antimicrob. Agents Chemother. 50:8 (2006), 2632–2639.
35. Ladics, G.S., Bannon, G.A., Silvanovich, A., Cressman, R.F., Comparison of conventional FASTA identity searches with the 80 amino acid sliding window FASTA search for the elucidation of potential identities to known allergens. Mol. Nutr. Food. Res. 51:8 (2007), 985–998.
36. Lara-Villoslada, F., Sierra, S., Díaz-Ropero, M.P., Olivares, M., Xaus, J., Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713. J. Dairy Sci. 90:8 (2007), 3583–3589.
37. Li, G., Yang, M., Zhou, K., Zhang, L., Tian, L., Lv, S., et al. Diversity of duodenal and rectal microbiota in biopsy tissues and luminal contents in healthy volunteers. J. Microbiol. Biotechnol. 25:7 (2015), 1136–1145.
38. Liu, B., Pop, M., ARDB—antibiotic resistance genes database. Nucleic Acids Res. 37:Suppl. 1 (2009), D443–D447.
39. Liu, Y., An, H., Zhang, J., Zhou, H., Ren, F., Hao, Y., Functional role of tlyC1 encoding a hemolysin-like protein from Bifidobacterium longum BBMN68 in bile tolerance. FEMS Microbiol. Lett. 360:2 (2014), 167–173.
40. Loquasto, J.R., Barrangou, R., Dudley, E.G., Roberts, R.F., Short communication: the complete genome sequence of Bifidobacterium animalis subspecies animalis ATCC 25527(T) and comparative analysis of growth in milk with B. animalis subspecies lactis DSM 10140(T). J. Dairy Sci. 94:12 (2011), 5864–5870.
41. Lozo, J., Jovcic, B., Kojic, M., Dalgalarrondo, M., Chobert, J.M., Haertlé, T., Topisirovic, L., Molecular characterization of a novel bacteriocin and an unusually large aggregation factor of Lactobacillus paracasei subsp. paracasei BGSJ2-8, a natural isolate from homemade cheese. Curr. Microbiol. 55:3 (2007), 266–271.
42. Lyra, A., Forssten, S., Rolny, P., Wettergren, Y., Lahtinen, S.J., Salli, K., et al. Comparison of bacterial quantities in left and right colon biopsies and faeces. World J. Gastroenterol. 18:32 (2012), 4404–4411.
43. Magnuson, R.D., Hypothetical functions of toxin-antitoxin systems. J. Bacteriol. 189:17 (2007), 6089–6092.
44. Martinez, F.A.C., Balciunas, E.M., Converti, A., Cotter, P.D., de Souza Oliveira, R.P., Bacteriocin production by Bifidobacterium spp. A review. Biotechnol. Adv. 31:4 (2013), 482–488.
45. Martinez, R.M., Hulten, K.G., Bui, U., Clarridge, J.E., Molecular analysis and clinical significance of Lactobacillus spp. recovered from clinical specimens presumptively associated with disease. J. Clin. Microbiol. 52:1 (2014), 30–36.
46. Matsubara, V.H., Wang, Y., Bandara, H.M.H.N., Mayer, M.P.A., Samaranayake, L.P., Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl. Microbiol. Biotechnol. 100:14 (2016), 6415–6426.
47. Middlebrook, J.L., Dorland, R.B., Bacterial toxins: cellular mechanisms of action. Microbiol. Rev., 48(3), 1984, 199.
48. Milani, C., Duranti, S., Lugli, G.A., Bottacini, F., Strati, F., Arioli, S., et al. Comparative genomics of Bifidobacterium animalis subsp. lactis reveals a strict monophyletic bifidobacterial taxon. Appl. Environ. Microbiol. 79:14 (2013), 4304–4315.
49. Mitchell, C., Fredricks, D., Agnew, K., Hitti, J., Hydrogen-peroxide producing lactobacilli are associated with lower levels of vaginal IL1β, independent of bacterial vaginosis. Sex. Transm. Dis., 42(7), 2015, 358.
50. Morovic, W., Hibberd, A.A., Zabel, B., Barrangou, R., Stahl, B., Genotyping by PCR and high-throughput sequencing of commercial probiotic products reveals composition biases. Front. Microbiol., 7, 2016.
51. ® (Lactobacillus plantarum CECT 7527, 7528 and 7529): antibiotic resistance and 90-day repeated-dose study in rats. Food Chem. Toxicol. 92 (2016), 117–128.
52. National Research Council, Guide for the Care and Use of Laboratory Animals. eighth ed., 2011, National Academy Press.
53. OECD, Guideline for the testing of chemicals. 2008 Section 4., Part 425.
54. Overbeek, R., Olson, R., Pusch, G.D., Olsen, G.J., Davis, J.J., Disz, T., et al. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res. 42:D1 (2013), D206–D214.
55. Owaga, E.E., Chen, M.J., Chen, W.Y., Chen, C.W., Hsieh, R.H., Oral toxicity evaluation of kefir-isolatéd Lactobacillus kefiranofaciens M1 in Sprague–Dawley rats. Food Chem. Toxicol. 70 (2014), 157–162.
56. Pariza, M.W., Gilles, K.O., Kraak-Ripple, S.F., Leyer, G., Determining the safety of microbial cultures for consumption by humans and animals. Regul. Toxicol. Pharmacol. 73 (2015), 164–171.
57. Patro, J.N., Ramachandran, P., Barnaba, T., Mammel, M.K., Lewis, J.L., Elkins, C.A., Culture-independent metagenomic surveillance of commercially available probiotics with high-throughput next-generation sequencing. mSphere, 1(2), 2016 e00057–16.
58. Prozorov, A., Danilenko, V., Toxin-antitoxin systems in bacteria: apoptotic tools or metabolic regulators?. (00262617) Microbiology, 79(2), 2010.
59. Ricci, A., Allende, A., Bolton, D., Chemaly, M., Davies, R., Girones, R., et al. Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017. EFSA J., 15(7), 2017.
60. Rossi, M., Martínez-Martínez, D., Amaretti, A., Ulrici, A., Raimondi, S., Moya, A., Mining metagenomic whole genome sequences revealed subdominant but constant Lactobacillus population in the human gut microbiota. Environ. Microbiol. Rep. 8:3 (2016), 399–406.
61. Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., Järvinen, A., Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin. Infect. Dis. 42:5 (2006), e35–e44.
62. Sanders, M.E., Akkermans, L.M., Haller, D., Hammerman, C., Heimbach, J.T., Hörmannsperger, G., Huys, G., Safety assessment of probiotics for human use. Gut Microbes 1:3 (2010), 164–185.
63. Shokryazdan, P., Jahromi, M.F., Liang, J.B., Kalavathy, R., Sieo, C.C., Ho, Y.W., Safety assessment of two new Lactobacillus strains as probiotic for human using a rat model. PLoS One, 11(7), 2016, e0159851.
64. Stahl, B., Barrangou, R., Complete genome sequences of probiotic strains Bifidobacterium animalis subsp. lactis B420 and Bi-07. J. Bacteriol. 194:15 (2012), 4131–4132.
65. Sudha, M.R., Safety assessment studies of probiotic Saccharomyces boulardii strain Unique 28 in Sprague-Dawley rats. Benef. Microbes 2:3 (2011), 221–227.
66. Szabo, N.J., Dolan, L.C., Burdock, G.A., Shibano, T., Sato, S.I., Suzuki, H., et al. Safety evaluation of Lactobacillus pentosus strain b240. Food Chem. Toxicol. 49:1 (2011), 251–258.
67. Tobita, K., Yanaka, H., Otani, H., The antiallergic effects and acute toxicity of Lactobacillus crispatus KT-11 cultured in food grade medium. J. Agric. Food. Chem. 58:10 (2010), 6498–6502.
68. Ulsemer, P., Toutounian, K., Schmidt, J., Leuschner, J., Karsten, U., Goletz, S., Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964. Regul. Toxicol. Pharmacol. 62:2 (2012), 336–346.
69. UniProt Consortium, UniProt: the universal protein knowledgebase. Nucleic Acids Res. 45:D1 (2017), D158–D169.
70. US FDA, Good Laboratory Practice for Nonclinical Laboratory Studies. 2002 21CFR part 58.
71. US FDA, GRAS Exemption Claim and Exemption Notification for the Use in Infant Formula of Bifidobacterium, Lactobacillus and Streptococcus Thermophiles. 2002 GRN000049 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm266302.pdf.
72. US FDA, Acute oral toxicity tests. Redbook, 2000, 2003 IV.C.2.
73. US FDA, Guidance for Industry: Summary Table of Recommended Toxicological Testing for Additives Used in Food. 2006 https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/IngredientsAdditivesGRASPackaging/ucm054658.htm#ftn1.
74. US FDA, GRAS Exemption Claim and Exemption Notification for the Addition of Lactobacillus Casei, Subspecies Rhamnosus GG, (LGG) to the Exempt Infant Formula. 2008 Nutramigen LIPIL. GRN000231 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm264050.pdf.
75. US FDA, Generally Recognized as Safe (GRAS) Determination of Lactobacillus Reuteri Strain DSM 17938. 2008 GRN000254 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm264280.pdf.
76. US FDA, Generally Recognized as Safe (GRAS) Notification for the Use of Bifidobacterium Longum BB536 in Selected Foods. 2009 GRN000268 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm269214.pdf.
77. US FDA, Generally Recognized as Safe (GRAS) Determination for the Use of Lactobacillus Rhamnosus Strain HN001 (DR20™) in Conventional Foods. 2009 GRN000288 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm269267.pdf.
78. ®. 2011 GRN000357 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm266351.pdf.
79. US FDA, Generally Recognized as Safe (GRAS) Determination for the Use of Bifidobacterium Animalis Ssp. Lactis Strain Bf-6 in Conventional Foods. 2011 GRN000377 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm274422.pdf.
80. US FDA, Generally Recognized as Safe (GRAS) Determination of Lactobacillus Reuteri Strain DSM 17938 for Addition to Term Infant Formula. 2012 GRN000410 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm287952.pdf.
81. US FDA, Generally Recognized as Safe (GRAS) Determination for the Use of Lactobacillu Casei Strain Shirota as a Food Ingredient. 2012 GRN000429 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm309143.pdf.
82. US FDA, Lactobacillus Reuteri NCIMB 30242 GRAS Notice. 2013 GRN000440 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm322242.pdf.
83. US FDA, GRAS Notice-exemption Claim for Bifidobacterium Animalis Ssp. Lactis Isolates, HN019, Bi-07, Bl-04 and B420. 2013 GRN000445 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm337456.pdf.
84. US FDA, Generally Recognized as Safe (GRAS) Determination for Bifidobacterium Breve M-16V in Selected Conventional and Medical Foods. 2013 GRN000453 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm346877.pdf.
85. US FDA, Generally Recognized as Safe (GRAS) Determination for Bifidobacterium Breve M-16V in Term Infant Formulas and Exempt Term Infant Formulas. 2013 GRN000454 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm346879.pdf.
86. US FDA, Generally Recognized as Safe (GRAS) Determination for Bifidobacterium Breve M-16V in Exempt Term Infant Formulas. 2013 GRN000455 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm346881.pdf.
87. US FDA, GRAS Notice-exemption Claim for Lactobacillus Acidophilus La-14. 2014 GRN000502 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm400673.pdf.
88. US FDA, Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. 2015 21 CFR part 111.
89. US FDA, GRAS Notification, Lactobacillus Fermentum CECT5716, Version 1. 2015 GRN000531 https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm422874.pdf.
90. Wagner, W., Vogel, M., Goebel, W., Transport of hemolysin across the outer membrane of Escherichia coli requires two functions. J. Bacteriol. 154:1 (1983), 200–210.
91. Wang, I.N., Smith, D.L., Young, R., Holins: the protein clocks of bacteriophage infections. Annu. Rev. Microbiol. 54:1 (2000), 799–825.
92. ®;, a non-toxigenic and non-pathogenic Bacillus cereus var. toyoi preparation. Regul. Toxicol. Pharmacol. 55:2 (2009), 236–246.
93. Yakabe, T., Moore, E.L., Yokota, S., Sui, H., Nobuta, Y., Fukao, M., et al. Safety assessment of Lactobacillus brevis KB290 as a probiotic strain. Food Chem. Toxicol. 47:10 (2009), 2450–2453.
94. Zhang, Z.Y., Liu, C., Zhu, Y.Z., Wei, Y.X., Tian, F., Zhao, G.P., Guo, X.K., Safety assessment of Lactobacillus plantarum JDM1 based on the complete genome. Int. J. Food Microbiol. 153:1 (2012), 166–170.
95. Zhou, J.S., Shu, Q., Rutherfurd, K.J., Prasad, J., Birtles, M.J., Gopal, P.K., Gill, H.S., Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. Int. J. Food Microbiol. 56:1 (2000), 87–96.
96. Zhou, J.S., Shu, Q., Rutherfurd, K.J., Prasad, J., Gopal, P.K., Gill, H.S., Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem. Toxicol. 38:2 (2000), 153–161.
97. Zhou, J.S., Gopal, P.K., Gill, H.S., Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. Int. J. Food Microbiol. 63:1 (2001), 81–90.
98. Zhou, C.E., Smith, J., Lam, M., Zemla, A., Dyer, M.D., Slezak, T., MvirDB—a microbial database of protein toxins, virulence factors and antibiotic resistance genes for bio-defence applications. Nucleic Acids Res. 35:Suppl. _1 (2006), D391–D394.